---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-390562"
form_type: "8-K"
ticker: "TEVA"
cik: "0000818686"
company_name: "TEVA PHARMACEUTICAL INDUSTRIES LTD"
filed_at: "2026-09-14T20:06:27+00:00"
generated_at: "2026-09-14T20:07:10.906088+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Teva begins trading ordinary shares on NYSE; ADS program terminated

## Summary
- Effective Sept 14, 2026, Teva ordinary shares trade on NYSE under 'TEVA', replacing ADSs.
- Each American depositary share exchanged for one ordinary share; ADS program terminated.
- Shares continue to trade on Tel Aviv Stock Exchange under same symbol 'TEVA'.
- Ticker unchanged, but security type changes from ADS to ordinary share.

## SEC filing metadata
- accession: 0001193125-26-390562
- form_type: 8-K
- ticker: TEVA
- cik: 0000818686
- company_name: TEVA PHARMACEUTICAL INDUSTRIES LTD
- filed_at: 2026-09-14T20:06:27+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/818686/000119312526390562/0001193125-26-390562-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/818686/000119312526390562/d503082d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-390562
- JSON: https://secwatch.observer/filing/0001193125-26-390562.json
- Plain text: https://secwatch.observer/filing/0001193125-26-390562.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.